06/04/2025 11:46 AM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13D | |
04/15/2025 11:40 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:46 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:50 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:11 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:18 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:22 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:30 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2025 3:30 PM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2025 3:33 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEF 14A | |
03/11/2025 3:35 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NBY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
03/07/2025 6:07 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 6:08 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
02/06/2025 5:30 PM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025 3:58 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:58 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
01/23/2025 7:12 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
01/23/2025 7:13 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2025 3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 5:06 PM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
01/10/2025 6:03 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2024 6:00 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 3:12 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
12/09/2024 6:05 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/26/2024 3:08 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/22/2024 3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 7:10 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024 4:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/12/2024 3:52 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/08/2024 4:31 PM | Hudson Bay Capital Management LP (Filed by) NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024 3:46 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:15 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:19 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
10/16/2024 3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:19 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFM14A | |
09/25/2024 4:17 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form PREM14A | |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
07/29/2024 3:25 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 6:18 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 424B4 | |
07/26/2024 4:19 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form POS EX | |
Trump Makes Major Crypto Announcement (Ad) Pay close attention to what I'm about to share…
Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong.
One project stands to benefit more than any other – not by accident, but seemingly by design.
 Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! |
07/25/2024 11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024 7:49 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024 5:21 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/11/2024 7:50 AM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/11/2024 7:45 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:05 PM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/10/2024 8:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |